Case File
efta-01789927DOJ Data Set 10OtherEFTA01789927
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01789927
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Giuffrida, David J
Sent:
Wednesday, June 8, 2011 8:00 PM
To:
Epstein, Jeffrey (eevacation@gmail.corn)
Cc:
Barrett, Paul S
Subject:
Trade Details
Jeffrey,
=o:p>
You sold the PFE note up 17.1= ($513,000)
c=p>
Sold $5 MM / bought CNY 1 year forward (06/11/2012) @ 6=2E3636
Bought 2.5 MM of the ING FRN Preferreds (CUSIP 44978NAA3) @=97. Purchased for June 15th, 2011 settlement
(maturity =f the 5 MM Ford bonds)
=0:p>
Let me know if you have any questions.
Thanks again.
David J. Giuffrida
J.P. Morgan I Globa= Investment Opportunities Group
IRS Circular 230 Disclosure:
1
EFTA_R1_00117058
EFTA01789927
JPMorgan Chase & Co. and its affiliates do not provi=e tax advice. Accordingly, any discussion of U.S. tax
matters contained herein (including any attachments) is no= intended or written to be used, and cannot be used, in
connection with th= promotion, marketing or recommendation by anyone unaffiliated with JPMorg=n Chase & Co. of
any of the matters addressed herein or for the purp=se of avoiding U.S. tax-related penalties.
&n=sp;
=span style=sfont-size:11.0ptfont-family:"Calibri","sans-serif";color:=1F497D5
&nb=p;
c=p>
<=span>
From: Barrett, Paul S
Sent: Wednesday, June 08,=2011 12:16 PM
To: Jeffrey Epstein
Cc: Giuffrida, David=J
Subject: Pfizer
Hi Jeffrey<A>
Our Pfizer ma=ket plus has been a big beneficiary of the defensive sector rotation. We=are up 17% on the $3MM and we
feel that it is a good time to take profits=2E
Also lyr CNY forward points have come into less than a 2% premi=m and I think we should add $5MM to our $10MM
position.
2
EFTA_R1_00117059
EFTA01789928
Our =5MM of Ford bonds mature next week. As a replacement I would add $2.5M= ING Pfds at 97.00. We think these
could get called at 100 next year=2E The balance we should leave in cash for now.
Paul<=span>
=span style='font-size:10.5pt;font-family:COnsolas;color:ff1F497D'>Paul =arrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
=p class=MsoNormal>
This communicati=n is for informational purposes only. It is not intended as an offer or =olicitation for the purchase or
sale of any financial instrument or as an =fficial confirmation of any transaction. All market prices, data and oth=r
information are not warranted as to completeness or accuracy and are sub=ect to change without notice. Any
comments or statements made herein do =ot necessarily reflect those of JPMorgan Chase & Co., its subsidiaries a=d
affiliates. This transmission may contain information that =s privileged, confidential, legally privileged, and/or exempt
from disclos=re under applicable law. If you are not the intended recipient, you are =ereby notified that any disclosure,
copying, distribution, or use of the i=formation contained herein (including any reliance thereon) is STRICTLY
PR=HIBITED. Although this transmission and any attachments are believed to =e free of any virus or other defect that
might affect any computer system =nto which it is received and opened, it is the responsibility of the recip=ent to ensure
that it is virus free and no responsibility is accepted by J=Morgan Chase & Co., its subsidiaries and affiliates, as
applicable, for =ny loss or damage arising in any way from its use. If you received this =ransmission in error, please
immediately contact the sender and destroy th= material in its entirety, whether in electronic or hard copy format.
Th=nk you. Please refer to http://www.jpmorgan.com/pages/dis=losures for disclosures relating to European legal
entities.
3
EFTA_R1_00117060
EFTA01789929
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
eevacation@gmail.cornURL
http://www.jpmorgan.com/pages/dis=losuresRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.